Context Therapeutics (CNTX) PT Raised to $7 at Piper Sandler

March 24, 2026 8:54 AM

Piper Sandler analyst Biren Amin raised the price target on Context Therapeutics (NASDAQ: CNTX) to $7.00 (from $4.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found